Trinity Legacy Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Trinity Legacy Partners's LLY Position: Q2 2026 in Review
Trinity Legacy Partners increased its Eli Lilly (LLY) stake by 17% in Q2 2026, buying an estimated $576K and bringing the position to 3,961 shares worth $4.63M. The position accounts for 0.93% of the portfolio, ranked #46.
Trinity Legacy Partners first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Trinity Legacy Partners held 3,961 shares of Eli Lilly worth $4.63M as of Q2 2026.
- Trinity Legacy Partners bought 564 Eli Lilly shares in Q2 2026, an estimated $576K.
- Eli Lilly made up 0.93% of Trinity Legacy Partners's portfolio in Q2 2026, its #46 holding.
- Trinity Legacy Partners first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Trinity Legacy Partners's 13F filing for Q2 2026, filed 24 Jul 2026.